Menu
Back to Journals » Orphan Drugs: Research and Reviews » Volume 5
Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatment
Authors Ilene Weitz I
Received 18 May 2015
Accepted for publication 21 July 2015
Published 1 September 2015 Volume 2015:5 Pages 75—81
DOI https://doi.org/10.2147/ODRR.S73641
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 4
Editor who approved publication: Dr Lise Aagaard
Ilene Ceil Weitz
Jane Anne Nohl Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder characterized by hemolysis, cytopenias, bone marrow dysfunction, and thrombosis. Over the last 20 years, we have seen a dramatic unraveling of the pathophysiology of this rare and complex disorder. As a result, new therapies involving complement inhibition have been developed, changing our understanding of the disease and improving outcomes for affected patients.
Keywords: paroxysmal nocturnal hemoglobinuria, pathophysiology, treatment
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.